SHA:688443 Revenue

In the year 2025, Chongqing Genrix Biopharmaceutical had annual revenue of 230.72M CNY with 666.65% growth. Chongqing Genrix Biopharmaceutical had revenue of 23.17M in the quarter ending December 31, 2025, with 31.58% growth.

Revenue

230.72M

Revenue Growth

+666.65%

P/S Ratio

48.93

Revenue / Employee

310.53K

Employees

793

Market Cap

11.29B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	230.72M	200.63M	666.65%
Dec 31, 2024	30.09M	28.88M	2,384.11%
Dec 31, 2023	1.21M	736.26K	154.92%
Dec 31, 2022	475.24K	-38.72M	-98.79%
Dec 31, 2021	39.19M	38.10M	3,502.99%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chengdu Olymvax Biopharmaceuticals	704.16M
Hualan Biological Vaccine	1.20B
Pacific Shuanglin Bio-pharmacy	2.38B
Chengdu Easton Biopharmaceuticals	1.35B
Star Lake Bioscience Co., Inc.Zhaoqing Guangdong	15.90B
Vcanbio Cell & Gene Engineering Corp.,	1.42B
HitGen	525.57M
InventisBio	37.29M

Revenue Rankings